Clinical Uptake of Precision Medicine Advances in NSCLC: A Case Study in RET Fusions

This poster, presented at ASCO Quality Care 2022, features an analysis HCP awareness and application of RET fusion testing and integration of recently approved selective RET inhibitors into practice for appropriate patients with advanced NSCLC.


Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings